ATRC AtriCure Inc
Price (delayed)
$26.9
Market cap
$1.31B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.86
Enterprise value
$1.28B
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure
Highlights
The company's gross profit rose by 18% YoY and by 3.1% QoQ
ATRC's revenue is up by 18% year-on-year and by 3.7% since the previous quarter
ATRC's net income is down by 43% YoY and by 8% QoQ
AtriCure's EPS has decreased by 41% YoY and by 8% from the previous quarter
Key stats
What are the main financial stats of ATRC
Market
Valuations
Earnings
Shares outstanding
48.7M
Market cap
$1.31B
Enterprise value
$1.28B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.82
Price to sales (P/S)
2.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.98
Revenue
$429.95M
EBIT
-$32.41M
EBITDA
-$15.14M
Free cash flow
-$19.63M
Per share
Balance sheet
Liquidity
EPS
-$0.86
Free cash flow per share
-$0.42
Book value per share
$9.55
Revenue per share
$9.17
TBVPS
$6.44
Total assets
$597.27M
Total liabilities
$135.19M
Debt
$75.32M
Equity
$462.09M
Working capital
$191.63M
Debt to equity
0.16
Current ratio
4.13
Quick ratio
2.77
Net debt/EBITDA
2.03
Margins
Efficiency
Dividend
EBITDA margin
-3.5%
Gross margin
74.8%
Net margin
-9.3%
Operating margin
-8.1%
Return on assets
-6.7%
Return on equity
-8.7%
Return on invested capital
-14.5%
Return on capital employed
-6%
Return on sales
-7.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATRC stock price
How has the AtriCure stock price performed over time
Intraday
0.11%
1 week
2.63%
1 month
28.65%
1 year
-37.57%
YTD
-24.63%
QTD
18.14%
Financial performance
How have AtriCure's revenue and profit performed over time
Revenue
$429.95M
Gross profit
$321.8M
Operating income
-$34.84M
Net income
-$40.12M
Gross margin
74.8%
Net margin
-9.3%
ATRC's net income is down by 43% YoY and by 8% QoQ
The operating income has decreased by 41% YoY and by 10% from the previous quarter
The net margin has contracted by 21% YoY and by 3.3% from the previous quarter
The operating margin has declined by 19% year-on-year and by 5% since the previous quarter
Growth
What is AtriCure's growth rate over time
Valuation
What is AtriCure stock price valuation
P/E
N/A
P/B
2.82
P/S
2.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.98
AtriCure's EPS has decreased by 41% YoY and by 8% from the previous quarter
ATRC's price to book (P/B) is 45% lower than its 5-year quarterly average of 5.1 and 17% lower than its last 4 quarters average of 3.4
ATRC's P/S is 61% below its 5-year quarterly average of 7.6 and 23% below its last 4 quarters average of 3.8
ATRC's revenue is up by 18% year-on-year and by 3.7% since the previous quarter
Efficiency
How efficient is AtriCure business performance
The company's return on invested capital has shrunk by 73% YoY and by 12% QoQ
The ROE has contracted by 43% YoY and by 7% from the previous quarter
AtriCure's return on assets has decreased by 40% YoY and by 8% QoQ
AtriCure's ROS has decreased by 27% YoY and by 6% from the previous quarter
Dividends
What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATRC.
Financial health
How did AtriCure financials performed over time
The current ratio is up by 24% year-on-year and by 3.3% since the previous quarter
AtriCure's quick ratio has increased by 13% YoY and by 5% QoQ
The debt is 84% less than the equity
The debt to equity has declined by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.